Literature DB >> 15722183

ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia.

H Kölsch1, F Jessen, N Freymann, M Kreis, F Hentschel, W Maier, R Heun.   

Abstract

Different studies have investigated the effect of the angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism on the risk of Alzheimer dementia (AD). However, results on the association of the ACE-I allele with AD have been inconclusive. A recent meta-analysis reported an association of the I-allele with the risk of AD. A few small studies also investigated the effect of ACE polymorphism on the risk of vascular dementia (VD). We have investigated the effect of ACE I/D polymorphism in 351 AD and 155 VD patients and 348 healthy controls. We found the I/I genotype to be associated with an increased risk of AD, but not with the risk of VD. Cell-specific effects of ACE polymorphism are suggested, additional studies on neuronal cells might help to understand the role of this polymorphism in AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15722183     DOI: 10.1016/j.neulet.2004.11.062

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  23 in total

1.  Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.

Authors:  Matthew L Hemming; Dennis J Selkoe
Journal:  J Biol Chem       Date:  2005-09-09       Impact factor: 5.157

2.  Association of polymorphisms in the Angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community.

Authors:  Yan Meng; Clinton T Baldwin; Abdalla Bowirrat; Kristin Waraska; Rivka Inzelberg; Robert P Friedland; Lindsay A Farrer
Journal:  Am J Hum Genet       Date:  2006-03-16       Impact factor: 11.025

3.  Association of ACE Gene Insertion/Deletion Polymorphism with Suicidal Attempt in an Iranian Population.

Authors:  Elham Ghorbani; Mahsa Mohammadi; Seyed Kazem Malakouti; Hamed Mohammadi-Kangarani; Elaheh Abdollahi; Mansour Torab; Parvaneh Rahimi-Moghaddam
Journal:  Biochem Genet       Date:  2020-07-27       Impact factor: 1.890

4.  The insertion polymorphism in angiotensin-converting enzyme gene associated with the APOE epsilon 4 allele increases the risk of late-onset Alzheimer disease.

Authors:  Binbin Wang; Feng Jin; Ze Yang; Zeping Lu; Rui Kan; Shu Li; Chenguang Zheng; Li Wang
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

5.  Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.

Authors:  Kenneth E Bernstein; Yosef Koronyo; Brenda C Salumbides; Julia Sheyn; Lindsey Pelissier; Dahabada H J Lopes; Kandarp H Shah; Ellen A Bernstein; Dieu-Trang Fuchs; Jeff J-Y Yu; Michael Pham; Keith L Black; Xiao Z Shen; Sebastien Fuchs; Maya Koronyo-Hamaoui
Journal:  J Clin Invest       Date:  2014-03       Impact factor: 14.808

6.  Angiotensin-converting enzyme gene insertion-deletion polymorphism is a risk marker for Alzheimer's disease in a Chinese population: a meta-analysis of case-control studies.

Authors:  Ye Yuan; Jin-hua Piao; Ke Ma; Na Lu
Journal:  J Neural Transm (Vienna)       Date:  2015-01-18       Impact factor: 3.575

7.  Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions.

Authors:  H Qureischie; R Heun; J Popp; F Jessen; W Maier; S Schmitz; F Hentschel; P Kelemen; H Kölsch
Journal:  J Neural Transm (Vienna)       Date:  2009-01-28       Impact factor: 3.575

8.  An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3.

Authors:  Todd L Edwards; Margaret Pericak-Vance; Johnny R Gilbert; Jonathan L Haines; Eden R Martin; Marylyn D Ritchie
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-07-05       Impact factor: 3.568

9.  Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia.

Authors:  H K Wang; H C Fung; W C Hsu; Y R Wu; J C Lin; L S Ro; K H Chang; F J Hwu; Y Hsu; S Y Huang; G J Lee-Chen; C M Chen
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

10.  Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.

Authors:  Maya Koronyo-Hamaoui; Julia Sheyn; Eric Y Hayden; Songlin Li; Dieu-Trang Fuchs; Giovanna C Regis; Dahabada H J Lopes; Keith L Black; Kenneth E Bernstein; David B Teplow; Sebastien Fuchs; Yosef Koronyo; Altan Rentsendorj
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.